1235.1.443 Boehringer Ingelheim Investigational Site — Georgetown, Texas

1235.1.443 Boehringer Ingelheim Investigational Site is a clinical research site located in Georgetown, Texas, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

1235.1.443 Boehringer Ingelheim Investigational Site has participated in 1 clinical trials.

Therapeutic areas: Hypertension.

Sponsors: Boehringer Ingelheim.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Georgetown

Browse all research sites in Texas · View every site in Georgetown

• Southwestern University
• St. David's Georgetown Hospital
• GSK Investigational Site
• Research Site
• Pinnacle Clinical Research-Georgetown
• Advanced Medical Trials
• Amel Med LLC
• Care Access - Georgetown
• Pfizer Investigational Site
• San Gabriel Clinical Research
• Texas Movement Disorder Specialist
• 89bio Clinical Study Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 1235.1.443 Boehringer Ingelheim Investigational Site?

1235.1.443 Boehringer Ingelheim Investigational Site has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 1235.1.443 Boehringer Ingelheim Investigational Site conducted?

1235.1.443 Boehringer Ingelheim Investigational Site has 1 clinical trials on record. Their work covers Hypertension.

Is 1235.1.443 Boehringer Ingelheim Investigational Site accredited by Crixeo Clinical Trials?

1235.1.443 Boehringer Ingelheim Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 1235.1.443 Boehringer Ingelheim Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.